Is VBI Vaccines Inc halal to invest in?

As of July 2026, VBI Vaccines Inc VBIV is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is VBI Vaccines Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes VBI Vaccines Inc using these criteria to determine its compliance status.

Can Muslims buy shares of VBI Vaccines Inc?

Muslim investors may consider investing in VBI Vaccines Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is VBI Vaccines Inc classified as HALAL?

Musaffa determines the Shariah status of VBI Vaccines Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for VBI Vaccines Inc updated?

The Shariah compliance status of VBI Vaccines Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like VBI Vaccines Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of VBI Vaccines Inc?

You can check the latest Shariah compliance status of VBI Vaccines Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VBI Vaccines Inc VBIV

Last Updated: Nov 22, 12:00 AM·BE

VBIV Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, VBI Vaccines Inc is classified as halal.

HALAL

Report Source: 2024 1st Quarter Report

VBI Vaccines Inc. Stock Analysis VBIV

Germany Health Care Nano Cap Report: Q1, 2024

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The company is headquartered in Cambridge, Massachusetts and currently employs 131 full-time employees. The company went IPO on 2001-11-19. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The firm is focused on targeting and overcoming significant infectious diseases, including hepatitis B (HBV), coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). Its product pipeline includes an approved vaccine and multiple late- and early-stage investigational programs. PreHevbrio is its approved vaccine for hepatitis B. Its Prophylactic Candidates for coronavirus disease include VBI-2901, VBI-2905, VBI-2902, and others. VBI-1501 is its Prophylactic Candidate for cytomegalovirus. VBI-2601 and VBI-1901 are the therapeutic candidates for HBV and GBM.

Key Statistics of VBI Vaccines Inc (VBIV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

22.18K

P/E Ratio (TTM)

52 Week Range

$0.46$21.00

Market Cap

Avg. Volume

91.24K

Dividend Yield

Financial Metrics & Statements of VBI Vaccines Inc (VBIV)

Super Investors Invested in VBI Vaccines Inc (VBIV)

FAQ's for VBI Vaccines Inc (VBIV)

As of July 2026, VBI Vaccines Inc VBIV is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes VBI Vaccines Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in VBI Vaccines Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of VBI Vaccines Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of VBI Vaccines Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of VBI Vaccines Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.